baber/WOPTO huggingface dataset:
Patent NZ-577862-A (NZ)
Title: Apparatus for exposing subject to a flux of non-ionizing electromagnetic radiation
Inventor: CHERNYAKOV GENNADY MICHAILOVICH
IPC: A61H39/00
Filed: 2007-10-16
Abstract: An apparatus for optimizing a functional condition of human's vegetative system. The apparatus comprises a series-connected set of microwave oscillator, a modulator in the form of a quasi-random impulse generator, a radiating antenna in the form of a planer co-phasal array and a control unit connected to each of the units. The antenna is of a centimertric band circular-polarization type with a plane-wise fixed-thickness dielectric pad of material which is transparent to fields of the operating frequency range. The antenna can be of a stripline type and the striplines of the antenna divider arranged to assure circular polarisation of the field and to change direction of its rotation.
Patent NZ-581305-A (NZ)
Title: Method for cellular tissue multiplication from jatropha curcas
Inventor: ATEHORTUA GARCES LUCIA
IPC: C12N5/02
Filed: 2009-11-19
Abstract: Provided is a method for production of oil derived from multiplied individual cells from an explant of a plant seed wherein the method comprises: (a) obtaining an explant from the seed; (b) putting the explant derived from the seed in a culture medium; (c) breaking the intercellular unions of the explants tissue derived from the seed in said culture medium, wherein the explants generate individual cells; (d) incubating for a determined time the culture medium with the individual cells generated from the explants derived from the seed, wherein said individual cells are multiplied within the determined time; and, (e) extracting oil from the cells that multiplied from the individual cells generated from the explants derived from the seed. The plant can be Jatropha curcas.
Patent NZ-583912-A (NZ)
Title: Medical implant with coloured polymer, about stable core, able to be warmed, softened by electromagnetic radiation so as to be deformable
Inventor: BAHRE WOLF-FRIEDRICH
IPC: A61B17/04
Filed: 2007-09-17
Abstract: Disclosed is a medical implant made at least in part of a polymer. Said medical implant A) is made only in part of one or more biocompatible polymers, at least some of which contain a dye, have a reflective coating, or have their own color; or B) is entirely made of one or more biocompatible polymers, only some of which contain a dye, have a reflective coating, or have their own color; or C) comprises one or more biocompatible polymers which are coated at least in part with a dye film or a reflective layer; or D) at least some of the polymer has a coating which can absorb corresponding dyes when entering in contact with dye-containing body fluids, such that E) the colored or dye-containing polymers (A) or the polymer layers bordering the reflective (A) or dye-absorbent (D) coatings or coatings composed of a dye film can be heated and softened using electromagnetic radiation while the remaining parts of the implant remain solid.
Patent NZ-588776-A (NZ)
Title: Continuous Air Filling Type Air Enclosure and Method for Manufacturing the Same
Inventor: LIAO CHIEH-HUA
IPC: B65D30/22
Filed: 2010-10-26
Abstract: A continuous air filling type air enclosure is revealed. Air channels are formed by two inner membranes. A first outer membrane, a second outer membrane and the inner membranes are connected by first hot sealing lines. One second hot sealing line connects the first and the second outer membranes while the other connects both the first and the second outer membranes to adjacent inner membrane. Air inlets are formed on the second hot sealing line, between the inner membranes and air columns are formed among the first and the second outer membranes, and inner membranes connected by the first and the second hot sealing lines. Air flows through the air inlets, along the air channels, and into the air columns. Then the air presses inner membranes to attach with each other and close the air columns while the other end of inner membrane is separated to form gaps.
Patent NZ-590271-A (NZ)
Title: 9-hydroxy-3-substituted-4H-pyrido[1,2-a]pyrimidin-4-ones and 9-hydroxy-3-substituted-4H-pyrido[1,2-a]pyrimidin-4-thiones
Inventor: HUGGINS PENELOPE JANE
IPC: A61K31/47
Filed: 2007-04-13
Abstract: Disclosed are 9-hydroxy-3-substituted-4H-pyrido[1,2-a]pyrimidin-4-ones and 9-hydroxy-3-substituted-4H-pyrido[1,2-a]pyrimidin-4-thiones useful in the treatment of age-related macular degeneration.
Patent NZ-590343-A (NZ)
Title: Compositions monovalent for cd28 binding and methods of use
Inventor: MCKINNON MURRAY
IPC: C07K16/28
Filed: 2009-07-17
Abstract: Disclosed is a domain antibody (dAb) that binds to CD28 and prevents the binding of CD28 to CD80 and/or CD86, wherein said dAb does not cross-react with CTLA4. Also disclosed is the use of the domain antibody (dAb) for the preparation of a medicament for the treatment of a patient, wherein the patient has or is at risk of having an immune disease.
Patent NZ-590426-A (NZ)
Title: Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof
Inventor: BARBAGALLO ELODIE
IPC: A61P25/00
Filed: 2009-07-09
Abstract: Disclosed are substituted benzyl-cinnolin-one derivative represented by general formula (I), in the form of the base or of an addition salt with an acid. A process for preparing the compounds of formula (I) are also disclosed. Also disclosed is the use of the compounds of formula (I) in the preparation of a medicament for treating any pathology in which CB2 cannabinoid receptors are involved such as, pain, inflammatory diseases, autoimmune diseases, allergic diseases, infectious diseases, neurodegenerative diseases, cardiovascular diseases, cancers, gastrointestinal diseases, obesity, type II diabetes, insulin resistance and adipose tissue inflammation.
Patent NZ-593212-A (NZ)
Title: A shelving system
Inventor: DESMOND BRETT JOHN
IPC: A47F5/00
Filed: 2009-12-23
Abstract: 593212 Disclosed are a shelf module (1) and a partition. The present shelf module (1) includes partition retaining means to ensure lateral stability of the detachable partition. The shelf module (1) is defined by a pair of substantially parallel lengthwise extending edges (2) and a pair of substantially parallel end edges (4). The shelf module (1) further comprises an array of lengthwise extending slats (8) which are spaced apart across the width of the module (1). An array of ribs (10) extend between the slats (8) and are spaced apart along the length of the module (1). The slats (8) sit proud of the ribs (10) and define a level above that of the ribs (10). At least one pair of the slats (8) have outwardly and oppositely directed partition retaining connection means at or toward an upper edge between which a portion of a partition can be secured.
Patent NZ-593848-A (NZ)
Title: Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
Inventor: LIM NATHANIEL
IPC: A61K51/00
Filed: 2009-12-29
Abstract: ABSTRACT - 593848 The disclosure relates to a radiopharmaceutical composition for positron emission tomography (PET) imaging of neurodegenerative diseases of the brain comprising: an effective amount of 18F-radiolabeled ((E)-4-(2-(6-(2-(2-(2-[18F]fluoroethoxy)-ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine) (18FAV-45); about 10% (v/v) of ethyl alcohol; and about 90% v/v of 0.9% saline solution, wherein said saline solution comprises about 0.5% w/v sodium ascorbate, wherein the radiopharmaceutical composition has a pH of about 4.5 to about 8.0. Also disclosed is a process for preparing a mono Boc-protected vinylaniline compound of formula (I).
Patent NZ-599291-A (NZ)
Title: Antimicrobial compounds and methods of making and using the same
Inventor: DUFFY ERIN M
IPC: A61K31/519
Filed: 2010-10-15
Abstract: The present disclosure relates generally to the field of antimicrobial compounds and to methods of making and using them. These fused heterocycle compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. Fused heterocycle core structures present in the compounds include: pyrrolo[2,3-d]pyrimidin-2-ol, imidazo[1,2-a]pyrimidin-7-one, pyrimido[1,2-a]benzimidazol-2-one and pyrimido[1,2-a]indol-2-one
Patent NZ-601109-A (NZ)
Title: Pharmaceutical composition comprising oligopeptides, preferably cilengitide
Inventor: EBER MARCUS
IPC: A61K9/08
Filed: 2010-12-06
Abstract: discloses compositions comprising (a) a polymorphic form A1 of the inner salt of cyclo-(Arg-Gly-Asp-DPhe-NMeVal), wherein the polymorphich form has a solubility between 3mg/ml and 15mg/ml, (b)one or mor amphiphilic compounds having a molar weight in the range of 200 g/mol to 2000 g/ml and (c) water, with the provisio that the sums of (a), (b) and (c) add up to 70% or more w/v of the total composition and that at least 10% w/v of the contained polymorphic form A1 is present in the composition in a suspended or suspendable solid form.
Patent NZ-605450-A (NZ)
Title: Anti-siglec-15 antibody
Inventor: HIRUMA YOSHIHARU
IPC: C12P21/08
Filed: 2010-04-07
Abstract: Provided is an antibody which binds to a polypeptide comprising amino acid residues 39 to 165 of a specified Siglec-15 amino acid sequence and inhibits osteoclast formation and/or osteoclastic bone resorption, or a functional fragment of the antibody, wherein the antibody has specified sequences of the six CDRs.
Patent NZ-606993-A (NZ)
Title: Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
Inventor: EPSHTEIN OLEG ILIICH
IPC: C07K16/28
Filed: 2011-07-15
Abstract: Disclosed is a combination pharmaceutical composition comprising a) a homeopathic activated-potentiated form of an antibody to at least one cytokine and b) a homeopathic activated-potentiated form of an antibody to at least one receptor. Also disclosed is the use of a homeopathic activated-potentiated form of an antibody to at least one cytokine in the preparation of a first medicament for the treatment of infectious disease and use of a homeopathic activated-potentiated form of an antibody to at least one receptor in the preparation of a second medicament for the treatment of infectious disease, for administration substantially at the same time to a patient in need thereof.
Patent NZ-614219-A (NZ)
Title: Nebulizer
Inventor: HOLAKOVSKY HOLGER
IPC: A61M15/00
Filed: 2012-05-22
Abstract: Nebulizer for a fluid which includes a replaceable container containing the fluid and a housing part which can be detached or opened for replacing the container. The nebulizer has a securing device associated to the container preventing that a used container can be connected to or used with the nebulizer once more. The securing device has locking portions moveable apart from each other or radially or outwards at least after the used container has been detached from the nebulizer such that the used container cannot be connected to or used with the nebulizer once more.
Patent NZ-614657-A (NZ)
Title: Securing device
Inventor: MCKINLEY MATTHEW HENRY
IPC: E04H17/26
Filed: 2012-10-11
Abstract: A reel holder 1 including at least one hook 5 configured to attach the reel holder 1 to an elongate member 7, where the reel holder 1 includes a securing mechanism 6 configured to retain a portion of the elongate member 7 within at least a portion of the hook 5. The securing mechanism 6 is moveable between at least two positions by an actuating mechanism 2 and in one of the positions, the clearance between the securing mechanism 6 and the hooked portion 5 of the reel holder 1 is sufficient for the elongate member 7 to escape from the hooked portion of the reel holder 1. The securing mechanism 6 is retained in one of the positions via a biasing means
Patent NZ-630467-A (NZ)
Title: Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
Inventor: ERDMAN PAUL
IPC: C07D487/04
Filed: 2014-01-15
Abstract: Disclosed are heterocyclically substituted pyrrolo[2,3-d]pyrimidine derivatives as represented by general formula (I) and pharmaceutically acceptable salts, tautomers, stereoisomers, enantiomers, and isotopologues thereof, wherein: R1 is substituted or unsubstituted saturated, partially saturated, or unsaturated alkyl, substituted or unsubstituted saturated, or partially saturated cycloalkyl, or substituted or unsubstituted non-aromatic heterocyclyl; and R2 is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R3 is substituted or unsubstituted heterocyclyl or substituted or unsubstituted aryl; L is O; and wherein the remaining substituents are as defined herein; provided R3 is not pyridyl when R2 is pyrazolyl; and the compound is not N-methyl-N-[trans-3-[[5-(1-methyl-1H-pyrazol-4-yl)-2-[(1-methyl-1H-pyrazol-4-yI)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]cyclobutyl]-2-propenamide; or N-methyl-N-[trans-3-[[5-(1-methyl-1H-pyrazol-3-yl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]cyclobutyl]-2-propenamide. Representative compounds include N-methyl-4-(4-(cyclopentyloxy)-5-(4-hydroxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)benzamide, 4-(2-(1H-indazol-5-ylamino)-4-(cyclohexyloxy)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenol, 4-(4-(cyclopentyloxy)-5-(4-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-3-methoxy-N-methylbenzamide, 4-(4-(cyclopentyloxy)-5-(pyridin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-3-methoxy-N-methylbenzamide, (4-(5-(4-(4H-1,2,4-triazol-3-yl)phenyl)-4-methoxy-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-3-chlorophenyl)(morpholino)-methanone and 4-(cyclopentyloxy)-2-(2-methoxyphenylamino)-5-(2-methylbenzo[d]oxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidine. Also disclosed is a pharmaceutical composition which comprises an effective amount of a compound of as defined above, or a pharmaceutically acceptable salt, tautomer, stereoisomer, enantiomer, or isotopologue thereof, and a pharmaceutically acceptable carrier, excipient or vehicle, for the treatment or prevention of breast cancer.
Patent NZ-700295-A (NZ)
Title: Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles
Inventor: WEJSE PETER LANGBORG
IPC: A61P31/04
Filed: 2013-03-27
Abstract: The present invention relates to nanoparticle aggregates comprising osteopontin (OPN) and one or more particles containing calcium and/or strontium and to their use for reducing or preventing biofilm growth or for removing biofilm. The invention furthermore relates to the use of the nanoparticle aggregates for treating, alleviating or preventing biofilm-related diseases.
Patent NZ-705399-A (NZ)
Title: Perforated shrink wrap sleeves and containers
Inventor: DUPUIS GLEN A
IPC: B65D75/62
Filed: 2011-08-15
Abstract: Disclosed are a container (10) and a shrink wrap sleeve (30) suitable for covering a portion of a container (10) which has a circumference variation. The container (10) and shrink wrap sleeve (30) allow easier packaging of irregularly shaped containers as well as easy removable of the shrink wrap sleeve (30) by the orientation of the perforations. The container (10) comprises a container body (10) and an axially oriented shrink wrap sleeve (30). The container body (10) has a circumference variation along a vertical axis. The container body (10) further comprises a bottom surface (12) and a container opening (16) having a top surface (14). The axially oriented shrink wrap sleeve (30) covers a portion of the container body (10) and a portion of the container opening (16). A top edge (22) of the shrink wrap sleeve (30) allows the top surface (14) to remain exposed. A bottom edge (20) of the shrink wrap sleeve (30) allows the bottom surface (12) to remain exposed. The shrink wrap sleeve (30) comprises a pair of generally vertical perforations (32) which descend from the top edge (22) towards a circumferential perforation ring (34) which is oriented below the container opening (16). The shrink wrap sleeve (30) covering a portion of the container body (10) circumference variation has one of a smaller or larger circumference located at at least one point between the circumferential perforation ring (34) and the bottom edge (20). The smaller or larger circumference prevents the shrink wrap sleeve (30) from slipping off the container (10) after removal of the portion extending between the circumferential perforation ring (34) and the top edge (22).
Patent NZ-707489-A (NZ)
Title: A roof rail assembly
Inventor: LEES HUGH JOHN
IPC: A47H1/10
Filed: 2015-04-28
Abstract: Two-piece roof rail assembly (10) for a curtain sided vehicle, including a roof support (12) and a rail system (14). The roof support includes a beam section (16) and an upwardly open receiving groove (28) provided on the outer side (26) of the beam section. The rail system includes a downwardly open channel (30) defining a rail (32). The channel includes a downwardly extending lip (32) receivable in the groove (28), wherein downward force applied to the rail system is transferred through the receiving groove in the roof support. The invention provides for easy replacement of a damaged rail system, as this can be disconnected from the roof support and repaired and re-fitted into position or replaced, without the difficulty associated with also removing the roof support.
Patent NZ-709435-A (NZ)
Title: Method for disposing rocker arm rolling friction-based extendable and retractable rolling stroke sections in parallel, excavator or loader having rocker arm rolling stroke sections disposed in parallel
Inventor: LIU SUHUA
IPC: E21C35/00
Filed: 2013-11-26
Abstract: The present invention relates to the field of excavation or loading, and in particular, to a method for arranging rolling-friction stretching and retraction based rolling stroke sections of a rocker arm in parallel. The invention also relates to an excavator or loader comprising a rocker arm having rolling stroke sections arranged in parallel. The excavator or loader comprises a rocker arm, a machine body, and a work head, wherein the rocker arm comprises a front roller, a rear roller, a front roller raceway, a rear roller raceway, a telescopic arm, a telescopic support arm, and the like; the front roller raceway and the rear roller raceway are arranged in parallel; the front roller rolls within the front roller raceway; the rear roller rolls within the rear roller raceway; the front roller coordinates with the rear roller to support the telescopic arm to perform the rolling-friction stretching and retraction on the telescopic support arm by means of rolling friction; the work head is connected with the telescopic arm which drives the work head to stretch or retract; and the telescopic support arm is connected with the machine body.
Patent NZ-719104-A (NZ)
Title: Wound management device
Inventor: DAVISON ERIC
IPC: A61M1/00
Filed: 2014-09-26
Abstract: The objective technical problem to be solved is to provide an easier to use wound management device. The claimed invention solves this problem by providing an opening 20 which is moveable between open and closed conditions and that can be held in an open condition. This is advantageous because a user no longer has to hold the opening open whilst tending to a wound and there is no lid or fold over portion which could obstruct the opening, or any other part of the device, whilst a user is using the device.
Patent NZ-719720-A (NZ)
Title: Engineered human t cell receptors with high affinity for wt1
Inventor: SCHMITT THOMAS M
IPC: C07K14/725
Filed: 2014-11-21
Abstract: T cell receptors (TCRs) that have specificity for the WT1 antigen are provided. The TCRs include higher affinity TCRs that were engineered through the generation of mutational libraries of TCRs in a single-chain format, followed by selection for improved stability and affinity on the surface of yeast (i.e. directed evolution). In embodiments, the TCRs can be used in soluble form for targeted delivery in vivo, or as genes introduced into T cells in an adoptive T cell setting.
Patent NZ-724983-A (NZ)
Title: Gas fastening tool with re-injected air
Inventor: RICORDI CHRISTIAN
IPC: B25C1/08
Filed: 2013-12-26
Abstract: Pollution problems are considered nowadays with strong acuity and combustion gases emitted by gas fastening tools are polluting gases. The present invention aims to reduce such emissions by such tools by providing a gas fastening tool comprising, among other things, a duct provided with a downstream input mouth and an upstream output mouth on a gas pathway wherein the duct is independent of said air injection means such that, after firing and explosion of a gas mixture into the chamber of the tool, fresh air located under a piston of the tool is driven by the piston through said duct and into said chamber in order to improve the completion of combustion.
Patent NZ-732239-A (NZ)
Title: Determining the passing time of a moving transponder
Inventor: SIX MARK
IPC: G07C1/24
Filed: 2015-12-17
Abstract: Methods and systems for determining the passing time of a moving transponder (202) passing a detection antenna (206) of a base station (204) are described wherein the method comprises: during said passing exchanging a sequence of first signals (210) between a first transponder coil (228) and said detection antenna and a sequence of second signals (214) between a second transponder coil (232) and the detection antenna; associating said first and/or second signals with time instances indicating the time when said first and/or second signals are exchanged between said transponder and said base station; and, determining the passing time of said transponder on the basis of the signal strengths of said first and second signals and said time instances.
Patent NZ-739867-A (NZ)
Title: Aminonaphthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
Inventor: YEN YUN
IPC: A61K31/18
Filed: 2015-07-23
Abstract: The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination- proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.
Patent NZ-740289-A (NZ)
Title: Intelligent continuous manufacturing method via liquid cooling of dripping pills
Inventor: YAN KAIJING
IPC: A61J3/06
Filed: 2016-09-14
Abstract: An intelligent continuous manufacturing method via liquid cooling of dripping pills comprises the following steps: (1) feeding: weighing and transferring multiple materials respectively; (2) material combining: performing staged heating on the materials transferred in step (1), and mixing the same to obtain a material mixture, wherein an RSD of an effective ingredient in the material mixture ≤ 5%; (3) homogenizing: pressurizing the material mixture obtained in step (2), and increasing the temperature, so as to obtain a homogenized material having the RSD of the effective ingredient in the material mixture ≤ 5%; (4) dripping: performing vibration dripping on the homogenized material obtained in step (3) to obtain dripping pills, delivering the dripping pills into a cooling liquid to be cooled and then transferred; and (5) de-oiling: removing the cooling liquid on surfaces of the dripping pills obtained in step (4) via tilting centrifugation. The manufacturing method not only shortens the manufacturing process, but also ensures the dripping pill product to be more stable and homogeneous. In addition, high-speed centrifugation is used to reasonably de-oil the dripping pills to prevent contamination of the dripping pills and improve the circulation utilization rate of the cooling liquid.